MINIMAL SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLO ARTHRITIS OVER 2 YEARS OF BIMEKIZUMAB TREATMENT: RESULTS FROM A PHASE 3 OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Baraliakos, X. [1 ]
Ramiro, S. [2 ,3 ]
Maksymowych, W. P. [4 ]
Ostergaard, M. [5 ,6 ]
Massow, U. [7 ]
Fleurinck, C. [8 ]
Vaux, T. [9 ]
Prajapati, C. [9 ]
Marten, A. [7 ]
de Peyrecave, N. [8 ]
Poddubnyy, D. [10 ,11 ]
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany
[2] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[3] Zuyderland Med Ctr, Heerlen, Netherlands
[4] Univ Alberta, Dept Med, Edmonton, AB, Canada
[5] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[6] Rigshosp, Copenhagen Ctr Arthrit Res, Ctr Rheumatol, Glostrup, Denmark
[7] UCB Pharma, Monheim, Germany
[8] UCB Pharma, Brussels, Belgium
[9] UCB Pharma, Slough, Berks, England
[10] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany
[11] German Rheumatism Res Ctr, Dept Epidemiol, Berlin, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2024年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P70
引用
收藏
页码：69 / 70
页数：2
相关论文
共 50 条
  • [31] Radiographic progression is getting milder in patients with early rheumatoid arthritis.: Results of 3 cohorts over 5 years
    Sokka, T
    Kautiainen, H
    Häkkinen, A
    Hannonen, P
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (06) : 1073 - 1082
  • [32] THE ONE-YEAR RADIOGRAPHIC PROGRESSION AND MINIMAL DISEASE ACTIVITY IN EARLY PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TO TREAT-TO-TARGET STRATEGY (RESULTS OF AN ONGOING OPEN-LABEL REMARCA STUDY)
    Loginova, E.
    Korotaeva, T.
    Smirnov, A.
    Koltakova, A.
    Karateev, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 943 - 944
  • [33] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [34] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [35] Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial
    Achebe, Maureen Okam
    Hassab, Hoda M. A.
    Al-Kindi, Salam
    Brown, Clark
    Telfer, Paul
    Biemond, Bart J.
    Lipato, Thokozeni
    Davis, Mark
    Gray, Sarah
    Gordeuk, Victor R.
    BLOOD, 2023, 142
  • [36] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Terry, Ketti
    Kwok, Kenneth
    Lazariciu, Irina
    Nduaka, Chudy
    Connell, Carol A.
    DeMasi, Ryan
    Wang, Lisy
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study
    Sieper, Joachim
    Landewe, Robert
    Magrey, Marina
    Anderson, Jaclyn K.
    Zhong, Sheng
    Wang, Xin
    Lertratanakul, Apinya
    RMD OPEN, 2019, 5 (01):
  • [38] EFFECT OF SECUKINUMAB ON RADIOGRAPHIC PROGRESSION THROUGH 2 YEARS IN PATIENTS WITH ACTIVE PSA: END-OF-STUDY RESULTS FROM A PHASE 3 STUDY
    Tahir, Hasan
    Mease, Philip
    Landewe, Robert
    Rahman, Proton
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Readie, Aimee
    Mpofu, Shephard
    Delicha, Eumorphia-Maria
    Pricop, Luminita
    van der Heijde, Desiree
    RHEUMATOLOGY, 2020, 59 : 114 - +
  • [39] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 28-WEEK OPEN-LABEL PERIOD OF THE ABILITY-3 STUDY
    Landewe, R.
    Sieper, J.
    Inman, R.
    Pangan, A. L.
    Wang, X.
    Anderson, J. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 353 - 354
  • [40] Radiographic progression of structural joint damage over five years of baricitinib treatment in patients with rheumatoid arthritis: results from RA-BEYOND
    van der Heijde, D.
    Kartman, C. E.
    Xie, L.
    Beattie, S.
    Schlichting, D.
    Durez, P.
    Tanaka, Y.
    Fleischmann, R.
    Hanssen-Bauer, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 27 - 27
12345